GlassScriptPhysician profile
Pauline Sok
NPI 1083188486
$1,993.89
in general payments reported to CMS, 2019-2025
11 companies · $1,305 in 2025
The $1,305 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $221 · 2024: $468 · 2025: $1,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,964 · Education: $30.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,963.69 |
| Education | $30.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $702.69 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $668.73 | 2024-2025 | |
| Biogen, INC. | $270.71 | 2023-2024 | Tysabri, Vumerity |
| Axsome Therapeutics, INC. | $81.10 | 2025 | Symbravo |
| Emd Serono, INC. | $75.54 | 2023-2024 | |
| Celgene Corporation | $53.07 | 2023 | Zeposia |
| Medtronic, INC. | $47.71 | 2024 | Synchromedii |
| Boston Scientific Corporation | $29.00 | 2025 | Varithena Administration Pack |
| Amgen INC. | $26.03 | 2025 | Uplizna |
| Cycle Pharmaceuticals INC | $21.80 | 2025 | Tascenso Odt, Bafiertam |
| Genentech USA, INC. | $17.51 | 2024 | Ocrevus Zunovo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pauline Sok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.